Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AXGN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Joseph A. Tyndall Director | AXGN Axogen, Inc. | Sale | 3,500 | $49.70 | $173.9K Sale | Form 4 ↗ |
| Aug 11, 2026 | Wendell Amy McBride Director | AXGN Axogen, Inc. | Sale | 13,353 | $48.42 | $646.6K Sale | Form 4 ↗ |
| Aug 10, 2026 | Marc A. Began EVP & General Counsel | AXGN Axogen, Inc. | Sale | 67,500 | $47.35 | $3.2M Sale | Form 4 ↗ |
| Aug 7, 2026 | Kathy Johnson Weiler Director | AXGN Axogen, Inc. | Sale | 14,150 | $45.30 | $641.0K Sale | Form 4 ↗ |
| May 8, 2026 | Wendell Amy McBride Director | AXGN Axogen, Inc. | Sale | 1,647 | $42.60 | $70.2K Sale | Form 4 ↗ |
| May 7, 2026 | John Johnson Director | AXGN Axogen, Inc. | Sale | 11,050 | $43.26 | $478.0K Sale | Form 4 ↗ |
| May 7, 2026 | Kathy Johnson Weiler Director | AXGN Axogen, Inc. | Sale | 16,344 | $44.09 | $720.6K Sale | Form 4 ↗ |
| May 7, 2026 | Jens Kemp Chief Marketing Officer | AXGN Axogen, Inc. | Sale | 4,000 | $43.44 | $173.8K Sale | Form 4 ↗ |
| May 7, 2026 | Lindsey Marie Hartley CFO | AXGN Axogen, Inc. | Sale | 573 | $43.67 | $25.0K Sale | Form 4 ↗ |
| May 7, 2026 | Lindsey Marie Hartley CFO | AXGN Axogen, Inc. | Sale | 478 | $43.67 | $20.9K Sale | Form 4 ↗ |
| May 7, 2026 | Doris Quackenbush Sales VP | AXGN Axogen, Inc. | Sale | 3,878 | $43.51 | $168.7K Sale | Form 4 ↗ |
| Mar 16, 2026 | Erick Wayne DeVinney Chief Innovation Officer | AXGN Axogen, Inc. | Sale | 5,221 | $32.84 | $171.5K Sale | Form 4 ↗ |
| Dec 16, 2025 | Wendell Amy McBride Director | AXGN Axogen, Inc. | Sale | 18,248 | $29.31 | $534.8K Sale | Form 4 ↗ |
| Dec 16, 2025 | Wendell Amy McBride Director | AXGN Axogen, Inc. | Sale | 20,436 | $29.31 | $599.0K Sale | Form 4 ↗ |
| Dec 16, 2025 | Wendell Amy McBride Director | AXGN Axogen, Inc. | Sale | 5,000 | $29.31 | $146.6K Sale | Form 4 ↗ |
| Dec 16, 2025 | Kathy Johnson Weiler Director | AXGN Axogen, Inc. | Sale | 6,580 | $29.55 | $194.4K Sale | Form 4 ↗ |
| Dec 16, 2025 | Kathy Johnson Weiler Director | AXGN Axogen, Inc. | Sale | 21,825 | $29.55 | $644.9K Sale | Form 4 ↗ |
| Dec 16, 2025 | Kathy Johnson Weiler Director | AXGN Axogen, Inc. | Sale | 18,248 | $29.55 | $539.2K Sale | Form 4 ↗ |
| Dec 15, 2025 | Lindsey Marie Hartley CFO | AXGN Axogen, Inc. | Sale | 14,812 | $29.86 | $442.3K Sale | Form 4 ↗ |
| Dec 11, 2025 | Marc A. Began EVP & General Counsel | AXGN Axogen, Inc. | Sale | 13,222 | $30.00 | $396.7K Sale | Form 4 ↗ |
| Dec 10, 2025 | Michael D. Dale Chief Executive Officer | AXGN Axogen, Inc. | Sale | 25,000 | $30.00 | $750.0K Sale | Form 4 ↗ |
| Dec 9, 2025 | John Johnson Director | AXGN Axogen, Inc. | Sale | 13,141 | $29.98 | $394.0K Sale | Form 4 ↗ |
| Dec 9, 2025 | John Johnson Director | AXGN Axogen, Inc. | Sale | 8,545 | $29.98 | $256.2K Sale | Form 4 ↗ |
| Dec 9, 2025 | Michael D. Dale Chief Executive Officer | AXGN Axogen, Inc. | Sale | 61,463 | $31.21 | $1.9M Sale | Form 4 ↗ |
| Dec 9, 2025 | Joseph A. Tyndall Director | AXGN Axogen, Inc. | Sale | 10,860 | $30.98 | $336.4K Sale | Form 4 ↗ |
| Dec 9, 2025 | Joseph A. Tyndall Director | AXGN Axogen, Inc. | Sale | 14,248 | $30.98 | $441.4K Sale | Form 4 ↗ |
| Dec 9, 2025 | Erick Wayne DeVinney Chief Innovation Officer | AXGN Axogen, Inc. | Sale | 19,517 | $31.21 | $609.1K Sale | Form 4 ↗ |
| Dec 9, 2025 | Jens Kemp Chief Marketing Officer | AXGN Axogen, Inc. | Sale | 8,156 | $31.21 | $254.5K Sale | Form 4 ↗ |
| Dec 9, 2025 | Marc A. Began EVP & General Counsel | AXGN Axogen, Inc. | Sale | 9,278 | $31.21 | $289.6K Sale | Form 4 ↗ |
| Dec 9, 2025 | Paul Thomas Director | AXGN Axogen, Inc. | Sale | 21,399 | $29.61 | $633.6K Sale | Form 4 ↗ |
| Dec 8, 2025 | John Johnson Director | AXGN Axogen, Inc. | Sale | 11,891 | $31.22 | $371.2K Sale | Form 4 ↗ |
| Dec 8, 2025 | John Johnson Director | AXGN Axogen, Inc. | Sale | 11,802 | $31.26 | $368.9K Sale | Form 4 ↗ |
| Dec 8, 2025 | Lindsey Marie Hartley CFO | AXGN Axogen, Inc. | Sale | 2,854 | $31.56 | $90.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Lindsey Marie Hartley CFO | AXGN Axogen, Inc. | Sale | 11,533 | $31.56 | $364.0K Sale | Form 4 ↗ |
| Nov 11, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 3,591 | $24.02 | $86.3K Sale | Form 4 ↗ |
| Nov 10, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 19,227 | $24.01 | $461.6K Sale | Form 4 ↗ |
| Nov 6, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 5,347 | $24.01 | $128.4K Sale | Form 4 ↗ |
| Nov 5, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 11,431 | $24.05 | $274.9K Sale | Form 4 ↗ |
| Oct 30, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 18,248 | $23.00 | $419.7K Sale | Form 4 ↗ |
| Oct 29, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 19,799 | $22.00 | $435.6K Sale | Form 4 ↗ |
| Oct 29, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 20,436 | $19.15 | $391.3K Sale | Form 4 ↗ |
| Oct 22, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 1,457 | $18.02 | $26.3K Sale | Form 4 ↗ |
| Oct 6, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 736 | $18.00 | $13.2K Sale | Form 4 ↗ |
| Oct 3, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 14,571 | $18.21 | $265.3K Sale | Form 4 ↗ |
| Oct 3, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 7,600 | $18.21 | $138.4K Sale | Form 4 ↗ |
| Oct 2, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 7,620 | $18.01 | $137.2K Sale | Form 4 ↗ |
| Oct 2, 2025 | Burke William P. Mr. Director | AXGN Axogen, Inc. | Sale | 2,400 | $18.01 | $43.2K Sale | Form 4 ↗ |
| Sep 16, 2025 | Erick Wayne DeVinney Chief Innovation Officer | AXGN Axogen, Inc. | Sale | 1,137 | $16.29 | $18.5K Sale | Form 4 ↗ |
| Jun 10, 2025 | Joseph A. Tyndall Director | AXGN Axogen, Inc. | Sale | 26,931 | $10.72 | $288.7K Sale | Form 4 ↗ |
| Jun 9, 2025 | Kathy Johnson Weiler Director | AXGN Axogen, Inc. | Sale | 4,073 | $10.61 | $43.2K Sale | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances